A Center for Testing Gene Editing Treatments
MU Rodent Testing Center for Somatic Cell Genome Editing
This center helps researchers test new gene editing treatments in animals to find better ways to treat human diseases.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Missouri-Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project ID | NIH-11169746 on NIH RePORTER |
What this research studies
This center provides specialized animal models and services to speed up the development of gene editing therapies for human diseases. Researchers can use mice and rats, which are important for testing new treatments before they are ready for people. The center has a team of experts in animal modeling and maintains high standards for animal care and research quality. This work helps ensure that future gene editing treatments are safe and effective by providing essential testing resources.
Who could benefit from this research
Good fit: Patients who might eventually benefit from new gene editing therapies for various human diseases are the ultimate focus of this foundational work.
Not a fit: Patients will not directly participate in this animal testing center, so there is no immediate direct benefit for individuals.
Why it matters
Potential benefit: If successful, this center will help accelerate the development of new gene editing therapies that could one day treat a wide range of human diseases.
How similar studies have performed: This center addresses a current need for specialized animal testing resources to advance gene editing, building upon the success of existing genome editing technologies.
Where this research is happening
Columbia, United States
- University of Missouri-Columbia — Columbia, United States (Active)
Researchers
- Principal investigator: Bryda, Elizabeth C — University of Missouri-Columbia
- Study coordinator: Bryda, Elizabeth C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.